Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

The Second Howard University Opioid and Naloxone Administration Training Symposium


Date: Sep 10, 2021 09:00 AM - 03:30 PM

CE Hours

5.50

CE Units

0.550

Registration closes on Nov 05, 2021 12:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Students
  • Physicians
  • Preceptors
  • Nurse Practitioners
  • Healthcare Professionals

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Support/Credits

This CE Activity is supported by an independent educational grant from the Opioid Anagesic REMS Program Companies.  This activity is intended to be fully compliant with the Opioid Analgesic REMS eduction requirements issued by the US Food and Drug Administration.
 
All grant funds were used to support the symposium's education and training.

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

   

Objectives

  • Identify the FDA's Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain
  • Define Pain
  • Explain the MOA of Pain
  • Explain the Basics of Pain Management
  • Outline a Pain Treatment Plan
  • Describe the appropriate use of Non-opioid and Opioid analgesic medications in pain management

Speaker(s)/Author(s)

Dr. Richard Schottenfeld

Activity Number

0010-0000-21-062-L08-P
Date: 09/10/21
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
   

   

Objectives

  • Outline treatment options based upon the type of pain - acute versus chronic
  • Recognize when to consult the PDMP
  • Classify Opioid Antagonists
  • Explain the signs of OUD
  • Define MOUD

Speaker(s)/Author(s)

Dr. Richard Schottenfeld

Activity Number

0010-0000-21-063-L08-P
Date: 09/10/21
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
   

   

Objectives

  • Describe current state of the overdose epidemic
  • State the Biden-Harris public policy solutions to address the overdose epidemic
  • Recognize the role pharmacists can play in treating and monitoring patients with OUD and preventing overdose

Speaker(s)/Author(s)

Attorney Regina LaBelle
Acting Director, White House Office of National Drug Control Policy

Activity Number

0010-0000-21-064-L08-P
Date: 09/10/21
Time: 11:30 AM - 12:00 PM

CE Hours

0.50
   

   

Objectives

  • Identify treatment barriers to care for Opioid Use Disorder.
  • Identify potential treatment and payment solutions.
  • Explain how to Achieve Triple (Quadruple) Aim.
  • State the acronym of ACE

Speaker(s)/Author(s)

Dr. Edwin Chapman

Activity Number

0010-000021-065-L08-P
Date: 09/10/21
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
   

   

Objectives

  • Describe the role of the pharmacist in expanding access to naloxone.
  • List potential barriers to the use of pharmacists to expand access to naloxone.
  • Report the evidence supporting the use of pharmacists in expanding naloxone and use.

Speaker(s)/Author(s)

Dr. Careen-Joan Franklin

Activity Number

0010-0000-21-066-L08-P
Date: 09/10/21
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
   

   

Objectives

  • Define the basic profile of opioids
  • Recognize the signs and symptoms of opioid overdose
  • Explain the pharmacology of Naloxone
  • Demonstrate proper administration of Narcan Nasal Spray
  • List the laws associated with naloxone administration and other harm reduction tools
  • Explain how to care for an individual after the administration of naloxone

Speaker(s)/Author(s)

Dr. Careen-Joan Franklin

Activity Number

0010-0000-21-067-L05-P
Date: 09/10/21
Time: 02:00 PM - 03:00 PM

CE Hours

1.00